Trial Profile
Oral aprepitant for prevention of chemotherapy-induced nausea and vomiting in Chinese patients receiving high-dose cisplatin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Granisetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 27 Jul 2011 New trial record
- 07 Jul 2011 Primary endpoint 'Complete-control-of-nausea-and-vomiting' has been met.
- 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.